![]() |
Volumn 877, Issue 20-21, 2009, Pages 1894-1900
|
A high-performance liquid chromatography-mass spectrometry assay for quantitation of the tyrosine kinase inhibitor nilotinib in human plasma and serum
|
Author keywords
AMN 107; Chronic myeloid leukemia; LC MS; Mass spectrometry; Nilotinib
|
Indexed keywords
AMN-107;
CHRONIC MYELOGENOUS LEUKEMIA;
CHRONIC MYELOID LEUKEMIA;
ELECTROSPRAY;
HUMAN PLASMAS;
INTER-ASSAY PRECISION;
INTRA-ASSAY PRECISION;
IONIZATION MASS SPECTROMETRY;
LC-MS;
NILOTINIB;
ORAL ADMINISTRATION;
PLASMA CONCENTRATION;
PROTEIN PRECIPITATION;
SMALL-MOLECULE INHIBITORS;
TYROSINE KINASE INHIBITOR;
ACETONITRILE;
AMINO ACIDS;
BODY FLUIDS;
CHROMATOGRAPHIC ANALYSIS;
ELECTROSPRAY IONIZATION;
HIGH PRESSURE LIQUID CHROMATOGRAPHY;
MASS SPECTROMETERS;
MASS SPECTROMETRY;
ORGANIC ACIDS;
PLASMA (HUMAN);
PLASMAS;
PRECIPITATION (CHEMICAL);
SPECTRUM ANALYSIS;
METHANOL;
NILOTINIB;
PROTEIN TYROSINE KINASE INHIBITOR;
WATER;
ACCURACY;
ARTICLE;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
DRUG STRUCTURE;
ELECTROSPRAY;
FOOD AND DRUG ADMINISTRATION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
IONIZATION;
MASS SPECTROMETER;
NORMAL HUMAN;
PLASMA;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
SEPARATION TECHNIQUE;
SERUM;
VALIDATION PROCESS;
VOLUNTEER;
ADULT;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DRUG STABILITY;
HUMANS;
MALE;
PROTEIN KINASE INHIBITORS;
PROTEIN-TYROSINE KINASES;
PYRIMIDINES;
SENSITIVITY AND SPECIFICITY;
SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;
|
EID: 67049172866
PISSN: 15700232
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jchromb.2009.05.034 Document Type: Article |
Times cited : (29)
|
References (14)
|